| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/19/2002 | EP0877750B1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents |
| 06/19/2002 | EP0866691B1 Sublingual and buccal administration of selegiline |
| 06/19/2002 | EP0753302B1 Osteoporosis preventing or treating agent |
| 06/19/2002 | EP0750504B1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus |
| 06/19/2002 | CN1354750A Amine derivatives compounds |
| 06/19/2002 | CN1354747A 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity |
| 06/19/2002 | CN1354742A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR)a |
| 06/19/2002 | CN1354672A Composition comprising alkaline sphingomyelinase for use as dietetic preparation, food supplement or pharmaceutical product |
| 06/19/2002 | CN1354661A Novel method of treatment |
| 06/19/2002 | CN1354659A Novel diphenylethylene compounds |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354012A Compound Chinese medicine tea bag for curing fatty liver and hyperlipemia and its production method |
| 06/19/2002 | CN1354000A Weight-reducing tea and its production method |
| 06/19/2002 | CN1353946A Cotyledon malacophylla tea and its function |
| 06/18/2002 | US6407211 Dendroaspis(green mamba snake) natriuretic peptide has at least one activity selected from the group consisting of vasodilation, antriuresis, diuresis and renin-suppressing activity |
| 06/18/2002 | US6407127 3-(4-(2-(5h-dibenzo(a,d)cyclohepten-5-yloxy)-ethoxyl-phenyl)-2 -ethoxy-propionic acid ethyl ester as antidiabetic agents and to treat obesity |
| 06/18/2002 | US6407110 Polyhydroxyalkylpyrazine derivatives and their preparation and medicines containing them |
| 06/18/2002 | US6407099 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same |
| 06/18/2002 | US6407095 Treating nicotinic receptor, gastrointestinal, nervous system, psychological, and brain disorders |
| 06/18/2002 | US6407094 Glutamate receptor antagonists |
| 06/18/2002 | US6407076 Adenosine analogues and related method of treatment |
| 06/18/2002 | US6406681 Propellents and drugs |
| 06/14/2002 | WO2001044187A1 Novel substituted tricyclic compounds |
| 06/14/2002 | CA2394778A1 Novel substituted tricyclic compounds |
| 06/13/2002 | WO2002046477A2 Endogenous retroviruses up-regulated in prostate cancer |
| 06/13/2002 | WO2002046458A2 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof |
| 06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | WO2002046423A2 Protein derived from the melanin-concentrating hormone (mch), corresponding nucleic acids and their use for preparing medicines |
| 06/13/2002 | WO2002046418A2 Lipid-associated molecules |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046406A2 Human transporter proteins, nucleic acid molecules encoding them,and uses thereof |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046383A2 Protein modification and maintenance molecules |
| 06/13/2002 | WO2002046373A1 Method of collecting placental stem cells |
| 06/13/2002 | WO2002046240A1 Multicomponent compositions containing chitosan and methods of preparing same |
| 06/13/2002 | WO2002046230A2 G-protein coupled receptors |
| 06/13/2002 | WO2002046227A2 Glp-1 fusion proteins |
| 06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors |
| 06/13/2002 | WO2002046184A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 06/13/2002 | WO2002046183A2 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 06/13/2002 | WO2002046181A2 Abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046174A1 1, 2, 4-oxadiazole derivatives as hppar alpha agonists |
| 06/13/2002 | WO2002046173A1 Fused heteroaromatic glucokinase activators |
| 06/13/2002 | WO2002046172A2 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046171A2 Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046170A2 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 06/13/2002 | WO2002046169A1 Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors |
| 06/13/2002 | WO2002046161A1 Substituted carboxylic acid derivatives |
| 06/13/2002 | WO2002046154A1 Peroxisome proliferator activated receptor d activators |
| 06/13/2002 | WO2002046148A1 Substituted anthranilic acids |
| 06/13/2002 | WO2002046146A1 Substituted carboxylic acid derivatives |
| 06/13/2002 | WO2002046141A2 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis |
| 06/13/2002 | WO2002046138A2 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines |
| 06/13/2002 | WO2002046134A1 Novel estrogen receptor ligands and methods iii |
| 06/13/2002 | WO2002045754A2 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 06/13/2002 | WO2002045712A1 Novel method and use |
| 06/13/2002 | WO2002045695A2 Hydrostatic delivery system for controlled delivery of agent |
| 06/13/2002 | WO2002045690A1 Synthesis of small particles |
| 06/13/2002 | WO2002045652A2 Tyrosine kinase inhibitors |
| 06/13/2002 | WO2002024701A3 Substituted azepino[4,5b)indole derivatives |
| 06/13/2002 | WO2002024700A3 SUBSTITUTED AZEPINO[4,5b]INDOLINE DERIVATIVES |
| 06/13/2002 | WO2002024213A3 Improved protocol for paracentesis |
| 06/13/2002 | WO2002008222A3 HETEROARYL-β-ALANINE DERIVATIVES AS ALPHA 4 INTEGRIN INHIBITORS |
| 06/13/2002 | WO2002008219A3 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 06/13/2002 | WO2002006286A3 IMIDAZO[1,2-a]PYRAZINES FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
| 06/13/2002 | WO2002006221A3 Cyclylamine sulfonamides as beta-3 adrenergic receptor agonists |
| 06/13/2002 | WO2002004404A3 7,8 and 9-substituted tetracycline compounds |
| 06/13/2002 | WO2001096330A3 Thrombin receptor antagonists |
| 06/13/2002 | WO2001094415A3 Nuclear hormone receptor |
| 06/13/2002 | WO2001090104A3 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases |
| 06/13/2002 | WO2001083550A3 Gpr22 modulators as appetite-control agents |
| 06/13/2002 | WO2001083438A3 New gamma selective retinoids |
| 06/13/2002 | WO2001074844A3 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 06/13/2002 | WO2001068828A3 Compositions and methods for regulated protein expression in gut |
| 06/13/2002 | WO2001037819A3 Use of indirubine derivatives for making medicines |
| 06/13/2002 | WO2001010444A3 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 06/13/2002 | WO1999059957A9 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 06/13/2002 | US20020072631 2-amino-2-alkyl-3 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 06/13/2002 | US20020072630 Therapy |
| 06/13/2002 | US20020072604 For prophylaxis and therapy of obesity, diabetes, sexual disorders, eating disorder; for modulating appetite and metabolic rates; for stimulating appetite of livestock for treatment of ketosis, postpartum anestrus |
| 06/13/2002 | US20020072537 Comprehensive pharmacologic therapy for treatment of obesity |
| 06/13/2002 | US20020072534 20- Hete antagonists and agonists |
| 06/13/2002 | US20020072526 Orally active salts with tyrosine kinase activity |
| 06/13/2002 | US20020072525 Aryl fused azapolycyclic compounds |
| 06/13/2002 | US20020072524 Aryl fused azapolycyclic compounds |
| 06/13/2002 | US20020072521 For therapy of central nervous system disorders such as stress, anxiety, depression, cardiovascular disorders, and eating disorders |
| 06/13/2002 | US20020072520 For use in therapy of hyperlipidemia and arteriosclerotic disorders |
| 06/13/2002 | US20020072518 Bicyclic alphavbeta3 antagonists |
| 06/13/2002 | US20020072517 Substituted cyclic amine metalloprotease inhibitors |
| 06/13/2002 | US20020072516 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders |
| 06/13/2002 | US20020072500 3-(carboxy(hydroxy)alkylaminocarbonylmethylaminocarbonyl), 5-(tetrahydropyrimidin-2-yl-amino)phenol for example |
| 06/13/2002 | US20020072485 Administering prior to the impairment of glucose and/or oxygen to the brain an NMDA receptor subunit (NR2B) selective NMDA antagonist to inhibit neuronal damage (ischemia) |
| 06/13/2002 | US20020072115 Pancreatic islet cell growth factors |
| 06/13/2002 | US20020072101 Novel human nucleic acid molecules and polypeptides encoding cation channels |
| 06/13/2002 | CA2716959A1 Glp-1 fusion proteins |
| 06/13/2002 | CA2678490A1 Isolated placental perfusate and placental cells isolated therefrom |
| 06/13/2002 | CA2436899A1 Synthesis, methods of using, and compositions of hydroxylated cyclobutylalkylamines |
| 06/13/2002 | CA2436870A1 Substituted anthranilic acids |
| 06/13/2002 | CA2436732A1 Protein modification and maintenance molecules |